Skip to content

All recalls FDA

FDADrugsRecalled Status: Ongoing

Tailstorm Health Inc recalls Lidocaine HCL Injection

Class IIofficial

FDA Class II

FDA classified this recall as Class II: the product may cause health problems that are temporary or can be treated; the chance of serious harm is remote.

Hazard
Subpotent Drug: reduced efficacy for epinephrine
Products
  • Lidocaine HCL Injection
Where it was sold

Nationwide in the USA

Nationwide

Barcodes
381483003802
Units affected
12,525 10 mL vials
About this recall
Lidocaine HCL Injection, USP 2% 200mg/10mL (20mg/mL) and EPINEPHRINE HCl 1:200,000, 10 ml Single Dose Vial, Rx only, Compounded drug by Medivant Healthcare, 158 S Kyrene Rd, Chandler, AZ 85226, NDC 81483-0038-0, UPC 3 81483 00380 2